As of Sep 22
| +0.04 / +0.23%|
The 24 analysts offering 12-month price forecasts for Teva Pharmaceutical have a median target of 23.00, with a high estimate of 35.00 and a low estimate of 14.00. The median estimate represents a +33.80% increase from the last price of 17.19.
The current consensus among 29 polled investment analysts is to Hold stock in Teva Pharmaceutical. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.